SOUTH
PLAINFIELD, N.J., Aug. 30,
2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:
PTCT) today announced that the company will present a company
overview at the following conferences:
Citi 2023 18th Annual BioPharma
Conference
Wednesday, Sept. 6,
at 9:40 a.m. EDT
Morgan Stanley 21st Annual Global
Healthcare Conference 2023
Monday,
Sept. 11, at 1:35 p.m. EDT
2023 Cantor Global Healthcare
Conference
Tuesday, Sept. 26,
at 12:25 p.m. EDT
The presentations will be webcast live on the Events and
Presentations page under the Investor section of PTC Therapeutics'
website at https://ir.ptcbio.com/events-presentations and will be
archived for 30 days following the presentation. It is recommended
that users connect to PTC's website several minutes prior to the
start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global
biopharmaceutical company focused on the discovery, development and
commercialization of clinically differentiated medicines that
provide benefits to patients with rare disorders. PTC's ability to
globally commercialize products is the foundation that drives
investment in a robust and diversified pipeline of transformative
medicines and our mission to provide access to best-in-class
treatments for patients who have an unmet medical need. The
company's strategy is to leverage its strong scientific expertise
and global commercial infrastructure to maximize value for its
patients and other stakeholders. To learn more about PTC, please
visit us at www.ptcbio.com and follow us on Facebook, on Twitter at
@PTCBio, and on LinkedIn.
For More Information:
Investors:
Kylie
O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine
Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301913095.html
SOURCE PTC Therapeutics, Inc.